212 related articles for article (PubMed ID: 29346407)
1. Relaxin reverses inflammatory and immune signals in aged hearts.
Martin B; Gabris-Weber BA; Reddy R; Romero G; Chattopadhyay A; Salama G
PLoS One; 2018; 13(1):e0190935. PubMed ID: 29346407
[TBL] [Abstract][Full Text] [Related]
2. Relaxin abrogates genomic remodeling of the aged heart.
Romero G; Salama G
Vitam Horm; 2021; 115():419-448. PubMed ID: 33706957
[TBL] [Abstract][Full Text] [Related]
3. Relaxin suppresses atrial fibrillation in aged rats by reversing fibrosis and upregulating Na+ channels.
Henry BL; Gabris B; Li Q; Martin B; Giannini M; Parikh A; Patel D; Haney J; Schwartzman DS; Shroff SG; Salama G
Heart Rhythm; 2016 Apr; 13(4):983-91. PubMed ID: 26711798
[TBL] [Abstract][Full Text] [Related]
4. Cardioprotective actions of relaxin.
Martin B; Romero G; Salama G
Mol Cell Endocrinol; 2019 May; 487():45-53. PubMed ID: 30625345
[TBL] [Abstract][Full Text] [Related]
5. Relaxin reverses maladaptive remodeling of the aged heart through Wnt-signaling.
Martin B; Gabris B; Barakat AF; Henry BL; Giannini M; Reddy RP; Wang X; Romero G; Salama G
Sci Rep; 2019 Dec; 9(1):18545. PubMed ID: 31811156
[TBL] [Abstract][Full Text] [Related]
6. Relaxin reduces susceptibility to post-infarct atrial fibrillation in mice due to anti-fibrotic and anti-inflammatory properties.
Beiert T; Tiyerili V; Knappe V; Effelsberg V; Linhart M; Stöckigt F; Klein S; Schierwagen R; Trebicka J; Nickenig G; Schrickel JW; Andrié RP
Biochem Biophys Res Commun; 2017 Aug; 490(3):643-649. PubMed ID: 28634079
[TBL] [Abstract][Full Text] [Related]
7. Relaxin reverses cardiac and renal fibrosis in spontaneously hypertensive rats.
Lekgabe ED; Kiriazis H; Zhao C; Xu Q; Moore XL; Su Y; Bathgate RA; Du XJ; Samuel CS
Hypertension; 2005 Aug; 46(2):412-8. PubMed ID: 15967869
[TBL] [Abstract][Full Text] [Related]
8. Effects of relaxin on rat atrial myocytes. I. Inhibition of I(to) via PKA-dependent phosphorylation.
Piedras-Rentería ES; Sherwood OD; Best PM
Am J Physiol; 1997 Apr; 272(4 Pt 2):H1791-7. PubMed ID: 9139964
[TBL] [Abstract][Full Text] [Related]
9. Modifications in relaxin's serum levels during acetate-free biofiltration (AFB): only a new biomarker?
Cernaro V; Lacquaniti A; Giorgianni G; Bolignano D; Buemi M
Ital J Anat Embryol; 2013; 118(1 Suppl):98-9. PubMed ID: 24640584
[TBL] [Abstract][Full Text] [Related]
10. Liver function, in-hospital, and post-discharge clinical outcome in patients with acute heart failure-results from the relaxin for the treatment of patients with acute heart failure study.
van Deursen VM; Edwards C; Cotter G; Davison BA; Damman K; Teerlink JR; Metra M; Felker GM; Ponikowski P; Unemori E; Severin T; Voors AA
J Card Fail; 2014 Jun; 20(6):407-13. PubMed ID: 24642379
[TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of relaxin: from basic science to clinical therapy.
Du XJ; Bathgate RA; Samuel CS; Dart AM; Summers RJ
Nat Rev Cardiol; 2010 Jan; 7(1):48-58. PubMed ID: 19935741
[TBL] [Abstract][Full Text] [Related]
12. Relaxin therapy reverses large artery remodeling and improves arterial compliance in senescent spontaneously hypertensive rats.
Xu Q; Chakravorty A; Bathgate RA; Dart AM; Du XJ
Hypertension; 2010 May; 55(5):1260-6. PubMed ID: 20351343
[TBL] [Abstract][Full Text] [Related]
13. Biological significance of miR-126 expression in atrial fibrillation and heart failure.
Wei XJ; Han M; Yang FY; Wei GC; Liang ZG; Yao H; Ji CW; Xie RS; Gong CL; Tian Y
Braz J Med Biol Res; 2015 Nov; 48(11):983-9. PubMed ID: 26313139
[TBL] [Abstract][Full Text] [Related]
14. TREK-1 (K
Lugenbiel P; Wenz F; Syren P; Geschwill P; Govorov K; Seyler C; Frank D; Schweizer PA; Franke J; Weis T; Bruehl C; Schmack B; Ruhparwar A; Karck M; Frey N; Katus HA; Thomas D
Basic Res Cardiol; 2017 Jan; 112(1):8. PubMed ID: 28005193
[TBL] [Abstract][Full Text] [Related]
15. The positive inotropic effect of relaxin-2 in human atrial myocardium is preserved in end-stage heart failure: role of G(i)-phosphoinositide-3 kinase signaling.
Dschietzig T; Alexiou K; Kinkel HT; Baumann G; Matschke K; Stangl K
J Card Fail; 2011 Feb; 17(2):158-66. PubMed ID: 21300306
[TBL] [Abstract][Full Text] [Related]
16. Relaxin decreases renal interstitial fibrosis and slows progression of renal disease.
Garber SL; Mirochnik Y; Brecklin CS; Unemori EN; Singh AK; Slobodskoy L; Grove BH; Arruda JA; Dunea G
Kidney Int; 2001 Mar; 59(3):876-82. PubMed ID: 11231342
[TBL] [Abstract][Full Text] [Related]
17. Rhodiola Inhibits Atrial Arrhythmogenesis in a Heart Failure Model.
Liu SH; Hsiao YW; Chong E; Singhal R; Fong MC; Tsai YN; Hsu CP; Chen YC; Chen YJ; Chiou CW; Chiang SJ; Chang SL; Chen SA
J Cardiovasc Electrophysiol; 2016 Sep; 27(9):1093-101. PubMed ID: 27255210
[TBL] [Abstract][Full Text] [Related]
18. Relaxin for the treatment of patients with acute heart failure (Pre-RELAX-AHF): a multicentre, randomised, placebo-controlled, parallel-group, dose-finding phase IIb study.
Teerlink JR; Metra M; Felker GM; Ponikowski P; Voors AA; Weatherley BD; Marmor A; Katz A; Grzybowski J; Unemori E; Teichman SL; Cotter G
Lancet; 2009 Apr; 373(9673):1429-39. PubMed ID: 19329178
[TBL] [Abstract][Full Text] [Related]
19. H3 Relaxin Protects Against Myocardial Injury in Experimental Diabetic Cardiomyopathy by Inhibiting Myocardial Apoptosis, Fibrosis and Inflammation.
Zhang X; Pan L; Yang K; Fu Y; Liu Y; Chi J; Zhang X; Hong S; Ma X; Yin X
Cell Physiol Biochem; 2017; 43(4):1311-1324. PubMed ID: 28992627
[TBL] [Abstract][Full Text] [Related]
20. Effects of relaxin on cardiac fibrosis, apoptosis, and tachyarrhythmia in rats with myocardial infarction.
Wang D; Zhu H; Yang Q; Sun Y
Biomed Pharmacother; 2016 Dec; 84():348-355. PubMed ID: 27668534
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
